Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
(for at least one location)
Scottsdale/Phoenix, AZ, Austin, MN, Eau Claire, WI, Jacksonville, FL, Mankato, MN, Rochester, MN
Describes the nature of a clinical study. Types include:
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Study statuses change often. Please contact us for help.
Open for enrollment
Closed for enrollment
Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL
The purpose of this study is to compare the effectiveness of two approaches for the management of Barrett's Esophagus (BE) and Low-grade Dysplasia (LGD), endoscopic surveillance and endoscopic eradication therapy (EET), using accepted clinical endpoints of neoplastic progression [high-grade dysplasia (HGD)/mucosal esophageal adenocarcinoma (EAC)/invasive EAC] as determined by a blinded central committee.